132 related articles for article (PubMed ID: 6545227)
1. In vivo skin test in carcinoma bladder.
Gupta NP; Rajagopal V; Malaviya AN; Singh SM
Indian J Cancer; 1984 Nov-1985 Jan; 21(5-6):163-5. PubMed ID: 6545227
[No Abstract] [Full Text] [Related]
2. Therapeutic implications of cellular immune defects in operable cancer patients revealed by dinitrochlorobenzene skin contact sensitivity.
Ketcham AS; Chretien PB
Panminerva Med; 1975; 17(5-6):174-8. PubMed ID: 1057759
[No Abstract] [Full Text] [Related]
3. Immunocompetence of patients with transitional cell carcinoma as measured by dinitrochlorobenzene skin tests and in vitro lymphocyte function.
Bean MA; Schellhammer PS; Herr HW; Pinsky CM; Whitmore WF
Natl Cancer Inst Monogr; 1978 Dec; (49):111-4. PubMed ID: 155219
[TBL] [Abstract][Full Text] [Related]
4. [The prognostic significance of the immune status (DNCB-test) in patients with carcinoma of the bladder, checked by observation of the course of disease (author's transl)].
Flamm J; Burkert S
Wien Med Wochenschr; 1981; 131(13-14):339-43. PubMed ID: 7281701
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of host immunocompetence in urologic cancer patients.
Catalona WJ; Smolev JK; Harty JI
J Urol; 1975 Dec; 114(6):922-6. PubMed ID: 1195475
[TBL] [Abstract][Full Text] [Related]
6. Immunological responsiveness in patients with bladder cancer.
Fahey JL; Brosman S; Dorey F
Cancer Res; 1977 Aug; 37(8 Pt 2):2875-8. PubMed ID: 872117
[TBL] [Abstract][Full Text] [Related]
7. Immunologic reduction of bladder cancer recurrence rate.
Olsson CA; Chute R; Rao CN
Trans Am Assoc Genitourin Surg; 1973; 65():66-72. PubMed ID: 4763514
[No Abstract] [Full Text] [Related]
8. Chemoprophylaxis of bladder cancer recurrence: immunological aspects.
Corrado F; Lalanne G; Pizza GC
Panminerva Med; 1974 Mar; 16(3):85-91. PubMed ID: 4217438
[No Abstract] [Full Text] [Related]
9. [DNCB test and immune competence. Analysis of patients with urologic neoplasms].
Klippel KF; Walz HP; Kreutz G; von Moltke T
MMW Munch Med Wochenschr; 1978 Aug; 120(31):1027-8. PubMed ID: 308155
[No Abstract] [Full Text] [Related]
10. Diminished contact sensitivity response in vitiliginous skin.
Uehara M; Miyauchi H; Tanaka S
Arch Dermatol; 1984 Feb; 120(2):195-8. PubMed ID: 6696471
[TBL] [Abstract][Full Text] [Related]
11. Clinical usefulness of rheumatoid factor in urinary bladder tumours--a preliminary report.
Singh SM; Gupta NP; Malaviya AN
Indian J Med Res; 1977 Apr; 65(4):563-5. PubMed ID: 908609
[No Abstract] [Full Text] [Related]
12. Evaluation of cellular mediated immunity in a normal adult population.
Robert F; Lozada JA; Muñiz FJ
Bol Asoc Med P R; 1977 Feb; 69(2):64-9. PubMed ID: 265703
[No Abstract] [Full Text] [Related]
13. [6 cases of second primary neoplasms].
Ardiles A; Aldunate C; Lagos M; Larraín P; Martínez C; Olivares R
Rev Med Chil; 1990 Nov; 118(11):1291-3. PubMed ID: 1967110
[No Abstract] [Full Text] [Related]
14. [The quantitative dinitrochlorobenzene hypersensitivity test in acquired syphilis].
Gliński W; Mazurkiewicz W; Brylak K; Gede K
Przegl Dermatol; 1984; 71(5):443-7. PubMed ID: 6528035
[No Abstract] [Full Text] [Related]
15. Immune response in bladder cancer.
Merrin C; Han T
J Urol; 1974 Feb; 111(2):170-2. PubMed ID: 4810757
[No Abstract] [Full Text] [Related]
16. [Examination of immunologic reaction of the cellular type using the DNCB test in patients with bone tumors (author's transl)].
Lipenský R; Urban K
Acta Chir Orthop Traumatol Cech; 1979 Dec; 46(6):485-90. PubMed ID: 532518
[No Abstract] [Full Text] [Related]
17. [2,4-dinitrochlorobenzene (DNCB) in the study of delayed hypersensitivity in some infectious diseases].
Cirelli A; D'Amato C; Lanzalone CM
Boll Soc Ital Biol Sper; 1974 Aug; 50(15):1157-62. PubMed ID: 4549182
[No Abstract] [Full Text] [Related]
18. Studies on the dinitrochlorobenzene (DNCB) sensitization test.
Niwa Y; Niwa H; Kohmura J; Ou DW; Yokoyama MM
Ann Allergy; 1982 Feb; 48(2):108-12. PubMed ID: 7199878
[TBL] [Abstract][Full Text] [Related]
19. Specific red cell adherence test and unspecific immune response in patients with superficial bladder cancer.
Jakse G; Hofstädter F; Märk R
Urol Int; 1981; 36(3):171-7. PubMed ID: 7025414
[TBL] [Abstract][Full Text] [Related]
20. Skin tests with soluble tumor membrane antigens in patients with transitional cell cancers.
Hollinshead AC
Natl Cancer Inst Monogr; 1978 Dec; (49):255-6. PubMed ID: 748779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
